Janux Therapeutics (JANX) Earnings Date, Estimates & Call Transcripts $49.35 -0.66 (-1.32%) (As of 03:25 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 5EstimatedActual EPS (Aug. 7) -$0.11 Beat By $0.20 Consensus EPS (Aug. 7) -$0.31 Conference Call TranscriptConference Call AudioEarnings Press Release Get Janux Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for JANX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueJANX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.JANX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Brownstone Research My big AI project…On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.Just click here to register. Janux Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.41)($0.29)($0.36)Q2 20243($0.38)($0.21)($0.30)Q3 20243($0.40)($0.27)($0.34)Q4 20243($0.41)($0.27)($0.36)FY 202412($1.60)($1.04)($1.36)Q1 20253($0.47)($0.28)($0.39)Q2 20253($0.52)($0.28)($0.42)Q3 20253($0.58)($0.29)($0.45)Q4 20253($0.59)($0.30)($0.46)FY 202512($2.16)($1.15)($1.71)JANX Earnings Date and InformationJanux Therapeutics last posted its quarterly earnings data on August 7th, 2024. The reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.31) by $0.20. The firm had revenue of $8.90 million for the quarter, compared to the consensus estimate of $0.77 million. Its revenue was up 709.1% on a year-over-year basis. Janux Therapeutics has generated ($1.22) earnings per share over the last year (($1.22) diluted earnings per share). Earnings for Janux Therapeutics are expected to decrease in the coming year, from ($1.18) to ($1.76) per share. Janux Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off prior year's report dates.Read More Janux Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/5/2024(Estimated)------- 8/7/2024Q2 2024($0.31)($0.11)+$0.20($0.11)$0.77 million$8.90 million 5/7/2024Q1 2024($0.35)($0.30)+$0.05($0.30)$0.98 million$1.25 million 3/8/2024Q4 2023($0.37)($0.25)+$0.12($0.25)$0.98 million$2.46 million11/7/2023Q3 2023($0.46)($0.25)+$0.21($0.25)$1.22 million$2.52 million 8/8/2023Q2 2023($0.52)($0.42)+$0.10($0.42)$1.25 million$1.06 million 5/9/2023Q1 2023($0.49)($0.42)+$0.07($0.42)$1.69 million$2.05 million Get the Latest News and Ratings for JANX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Janux Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/10/2023Q4 2022($0.45)($0.39)+$0.06($0.39)$1.69 million$2.85 million 11/10/2022Q3 2022($0.51)($0.40)+$0.11($0.40)-$1.81 million 8/9/2022Q2 2022($0.37)($0.41)($0.04)($0.41)-$2.37 million 5/10/2022Q1 2022($0.37)($0.32)+$0.05($0.32)-$1.59 million 3/18/2022Q4 2021($0.30)($0.33)($0.03)($0.33)-$1.62 million 11/9/2021Q3 2021($0.18)($0.26)($0.08)($0.26)-$1.16 million 8/10/2021Q2 2021($0.14)($0.62)($0.48)($0.62)-$0.48 million Janux Therapeutics Earnings - Frequently Asked Questions When is Janux Therapeutics's earnings date? Janux Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates. Learn more on JANX's earnings history. Did Janux Therapeutics beat their earnings estimates last quarter? In the previous quarter, Janux Therapeutics (NASDAQ:JANX) reported ($0.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.20. Learn more on analysts' earnings estimate vs. JANX's actual earnings. How can I listen to Janux Therapeutics's earnings conference call? The conference call for Janux Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Janux Therapeutics's conference call transcript? The conference call transcript for Janux Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Janux Therapeutics generate each year? Janux Therapeutics (NASDAQ:JANX) has a recorded annual revenue of $15.13 million. How much profit does Janux Therapeutics generate each year? Janux Therapeutics (NASDAQ:JANX) has a recorded net income of -$58.29 million. JANX has generated -$1.22 earnings per share over the last four quarters. What is Janux Therapeutics's EPS forecast for next year? Janux Therapeutics's earnings are expected to decrease from ($1.18) per share to ($1.76) per share in the next year. More Earnings Resources from MarketBeat Related Companies: PRAX Earnings Date SRRK Earnings Date IGMS Earnings Date FHTX Earnings Date OCGN Earnings Date PSTX Earnings Date NKTR Earnings Date CRBU Earnings Date RPTX Earnings Date ALXO Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:JANX) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Janux Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Janux Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
